A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer
Crossref DOI link: https://doi.org/10.1007/s00280-016-2973-2
Published Online: 2016-02-05
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shim, Hyun-Jeong
Kim, Ka-Rham
Hwang, Jun-Eul
Bae, Woo-Kyun
Ryu, Seong-Yeop
Park, Young-Kyu
Nam, Taek-Keun
Chung, Ik-Joo
Cho, Sang-Hee
Funding for this research was provided by:
Jeil Pharmaceutical Co., Ltd
Text and Data Mining valid from 2016-02-05